Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab A... Read More
Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Ret... Read More
Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Ret... Read More
Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination Wi... Read More
Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More
Dhaka, April 2 -- A bus driver's assistant has died after falling off a moving bus in Noakhali Sadar. The accident took place in the Maijdi Bazar area of the Chaumuhani-Maijdi road on Wednesday night... Read More
U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07504679) titled 'Adipose Visceral and Epicardial Risk Evaluation' on March 26. Brief Summary: The goal of t... Read More
U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07504536) titled 'Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia' on March 12. Brief Summ... Read More
U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07506187) titled 'The Role of Arginine in Oral Nutritional Supplementation in Preventing or Reducing Complica... Read More
U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505771) titled 'A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer' on March 18. Brief ... Read More